Iodine-125 implantation with transjugular intrahepatic portosystemic shunt for main portal vein tumor thrombus

Table 1 Baseline characteristics on patients

	TIPS-125I group(n = 40)	TIPS only group(n = 45)	P-value
Gender			0.961
Male	27	30
Female	13	15
Average age	51 ± 4.3	49 ± 6.9	0.311
Etiology			0.923
Hepatitis B or C	24	28
Alcoholic	8	7
Cholestasis	4	6
Other	4	4
Child-Push classification			0.384
A	6	10
B	20	16
C	14	19
Albumin (g/L)	30 ± 11	32 ± 11	0.915
Direct bilirubin (umol/L)	23.1 ± 16.9	21 ± 15	0.43
Alanine aminotransferase (U/L)	49 ± 36	53 ± 41	0.756
Aspartate aminotransferase (U/L)	42.5 ± 26.5	50.5 ± 37.5	0.318
Na+	135.5 ± 15.5	138.5 ± 16.5	0.384
K+	3.73 ± 1.27	3.49 ± 1.31	0.609
MELD score	11.96 ± 1.68	12.77 ± 2.49	0.187
Clinical symptoms			0.486
Hemorrhage	29	32
Chest and/or abdominal dropsy	6	5
Both	5	8
First-grade branch of portal vein			0.571
Unobstructed	18	22
Obstructed	22	23

TIPS: Transjugular intrahepatic portosystemic shunt; MELD score: Model for end-stage liver disease score.